Cardiometabolic Screening Program
Recruiting · NCT05386719 · Interventional (participants receive a specific treatment) · Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
View the official record on ClinicalTrials.gov →Interventions studied
Assess 10 year risk of cardiovascular eventBaselineFollow-UpInterpret BMIInterpret HbA1cInterpret lipid panel and assess other risk factorsPrescreeningRecommendationsScreening and Enrollment
What this trial is about
This research study is being done to implement a screening program for prediabetes, diabetes, dyslipidemia and/or hyperlipidemia, and higher risk of cardiovascular disease in breast cancer survivors. This program will also help to direct individuals with risk factors to community and institutional resources for management.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Diagnosis of early stage breast cancer
- Completed local and/or systemic therapy at least 3 months ago
- Receiving medical oncology care at through the breast cancer clinics at Johns Hopkins Medical Institute, including the Sidney Kimmel Comprehensive Cancer Center in Baltimore MD and Green Spring Station in Lutherville-Timonium MD, and Sibley Memorial Hospital in Washington D.C.
- Read and speak English
Exclusion criteria
- Metastatic breast cancer
Where it is running
1 location listed across 1 US state.
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins - Baltimore, Maryland, United States